[Form 4] OXBRIDGE RE HOLDINGS Ltd Insider Trading Activity

Rhea-AI Filing Summary

Allan S. Martin, a director of Oxbridge Re Holdings Ltd (symbol: OXBRW), reported a sale of ordinary shares on 09/16/2025. The Form 4 shows 4,328 shares sold at $2.4505 per share, with the filing signed by an attorney-in-fact on 09/19/2025. Following the reported transaction, Mr. Martin directly holds 216,803 ordinary shares (jointly with his wife) and indirectly holds 68,770 shares via Fleur de Lis Partners, LLLP and 102,223 shares via the Martin Family Foundation, Inc., with disclaimers that he disclaims beneficial ownership of the indirectly held shares except to the extent of his pecuniary interest.

Positive

• Transaction fully disclosed: Form 4 records the sale with price and date.
• Detailed ownership breakdown: Direct and indirect holdings are explicitly reported with explanatory footnotes.
• Standard disclaimers included: The reporting person disclaims beneficial ownership of indirectly held shares except to the extent of pecuniary interest.

Negative

• Insider sale occurred: Reporting person disposed of 4,328 ordinary shares.
• No context on reason: The form provides the sale but does not state any rationale for the transaction.

Insights

Financial Analyst

TL;DR: Routine insider sale of 4,328 shares at $2.4505; holding disclosures clarify direct and indirect positions.

The Form 4 documents a single non-derivative transaction: sale code S of 4,328 ordinary shares on 09/16/2025 at a price of $2.4505 per share. The filing lists a direct holding of 216,803 shares (held jointly) and indirect holdings of 68,770 and 102,223 shares through two entities, with explicit disclaimers of beneficial ownership for the indirect positions. As presented, this is a disclosure of position and a sale, not an operational or financial performance disclosure.

Corporate Governance Expert

TL;DR: The director properly reported a sale and disclosed indirect holdings with required disclaimers.

The submission includes the reporting person relationship as a Director and shows the required explanatory footnotes regarding indirect ownership via Fleur de Lis Partners, LLLP and the Martin Family Foundation, Inc. The form is signed by an attorney-in-fact, and the explanatory language includes the standard disclaimer that the reporting person disclaims beneficial ownership of the indirectly held securities except for any pecuniary interest. The filing meets standard disclosure elements for Section 16 reporting based on the content provided.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

MARTIN ALLAN S.

(Last) (First) (Middle)

101 E KENNEDY BLVD

SUITE 4110

(Street)

TAMPA FL 33602

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
OXBRIDGE RE HOLDINGS Ltd [ OXBR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/16/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	09/16/2025	09/17/2025	S		4,328	D	$2.4505	216,803(1)	D
Ordinary Shares								68,770(2)	I	See footnote 2
Ordinary Shares								102,223(3)	I	See footnote 3

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Ordinary shares held by Allan Martin and his wife, Marie Martin, jointly.

2. Ordinary Shares indirectly held in the name of Fleur de Lis Partners, LLLP. As the general partner of Fleur de Lis Partners, LLLP, Mr. Martin has voting and investment power over the ordinary shares held by that entity. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the reporting person's pecuniary interest in such securities.

3. Ordinary Shares indirectly held in the name of the Martin Family Foundation, Inc. As one of the directors of the Foundation, Inc. Mr. Martin has shared voting and shared investment power over the ordinary shares held by that entity. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the reporting person's pecuniary interest in such securities.

	/s/Jacqueline Baker, as Attorney-in-Fact for Allan Martin	09/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Allan S. Martin report on the Form 4 for OXBRW?

The Form 4 reports a sale of 4,328 ordinary shares on 09/16/2025 at a price of $2.4505 per share.

How many shares does Allan S. Martin directly and indirectly hold according to the filing?

The filing shows 216,803 shares directly (held jointly), 68,770 shares indirectly via Fleur de Lis Partners, LLLP, and 102,223 shares indirectly via the Martin Family Foundation, Inc.

What is the reporting person’s relationship to OXBRW?

The Form 4 lists Allan S. Martin as a Director of Oxbridge Re Holdings Ltd.

Does the filing include disclaimers about beneficial ownership?

Yes. The filing contains standard disclaimers stating the reporting person disclaims beneficial ownership of the indirectly held securities except to the extent of any pecuniary interest.

When was the Form 4 signed?

The form is signed by an attorney-in-fact, Jacqueline Baker, with the signature date of 09/19/2025.